RTTNews | Aug 4, 2021 06:07AM EDT

06:07 Wednesday, August 4, 2021 (RTTNews) - Pharmaxis Commences Final Cohort Dosing In Phase 1c Trial Of MF-101 For Bone Marrow Cancer Myelofibrosis

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved